Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost‐Effectiveness of Ivabradine for Heart Failure in the United States have?
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States has 36 citations in the OpenAlex counts ScholarIQ stores.
When was Cost‐Effectiveness of Ivabradine for Heart Failure in the United States published?
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States has 2016 year in the ScholarIQ index.
What is the open-access status of Cost‐Effectiveness of Ivabradine for Heart Failure in the United States?
Cost‐Effectiveness of Ivabradine for Heart Failure in the United States has gold oa status in the ScholarIQ index.
What is the DOI of Cost‐Effectiveness of Ivabradine for Heart Failure in the United States?
The DOI for Cost‐Effectiveness of Ivabradine for Heart Failure in the United States is on the source record.
What is the PMID of Cost‐Effectiveness of Ivabradine for Heart Failure in the United States?
The PMID for Cost‐Effectiveness of Ivabradine for Heart Failure in the United States is on the source record.
What is the OpenAlex record for Cost‐Effectiveness of Ivabradine for Heart Failure in the United States?
The OpenAlex for Cost‐Effectiveness of Ivabradine for Heart Failure in the United States is on the source record.